Larotrectinib companion diagnostic - Foundation Medicine
Alternative Names: Larotrectinib FoundationOne®CDx - Foundation MedicineLatest Information Update: 25 Sep 2024
At a glance
- Originator Foundation Medicine
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Solid tumours